Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data

Lancet

Volumn 355, Issue 9208, 2000, Pages 949-955

  Pignon, J P ^a   Bourhis, J ^a   Domenge, C ^a   Designe L ^a   Hill, C ^a,bo   Adelstein, D J ^b   Bachaud, J M ^c   Bezwoda, W R ^d   Buffoli, A ^e   Browman, G P ^f   Campbell, B H ^g   Carugati, A ^h   Clark, J R ⁱ   Collette, L ^j   Dal Canton, O ^k   Dalley, D ^l   Depont, J ^m   Deszcz Thomas, A ⁿ   Di Blasio, B ^o   Evensen, J F ^p   Fischer, J J ^q   Gedouin, D ^r   Geara, F ^s   Gupta, N K ^t   Haddad, E ^u   Haffty, B G ^q   Hasegawa, Y ^v   Horiuchi, M ^w   Houghton, J ^x   Jeremic, B ^y   Jouffroy, T ^z   Jortay, A ^aa   Kapstad, B ^ab   Kowalski, L P ^ac   Kramer, S ^ad   Krishnamurthi, K S ^ae   Laramore, G ^af   Lefebvre, J L ^ag   Leong, T ^ah   Lewin, F ^ai   Luboinski, B ^a   Maipang, T ^aj   Martin, M ^ak   Mazeron, J J ⁿ   Merlano, M ^al   Metha, S ^am   Morita, K ^v   Mosseri, V ^z   Murias, A ^an   Numico, G ^al   O Sullivan, B ^ao   Paccagnella, A ^ap   Pajak, T ^aq   Parvinen, L M ^ar   Pearlman, N W ^as   Rao, R S ^at   Richard, J M ^a   Sanchiz, F ^au   Sancho Garnier, H ^av   Schuller, D E ^aw   Shanta, V ^ae   Smid, L ^ax   Szpirglas, H ^ay   Schwaab, G ^a   Taylor, S G ^az   Takaku, S ^ba   Tobias, J S ^bb   Toohill, R J ^g   Volling, P ^bc   Weissler, M C ^bd   Wendt, T ^be   Wolf, G T ^bf   Yoshino, K ^bg   Armand, J P ^a   Guerin S ^a   Jan, P ^a   Luboinski, M ^a   Lefevbre, J L ^ag   Forastiere, A A ^bh   Bartelink, H G ^bi   Eschwege, F ^a   Fu, K K ^bj   Molinari, R ^bk   Simes, R J ^bl   Stewart, L A ^bm   Vokes, E E ^bn   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Instituto di Radioterapie Oncologica   (Italy)

^f MCMASTER UNIVERSITY   (Canada)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h Instituto de Oncologia Angel H Roffo   (Argentina)

ⁱ Dana Farber Metro West Cancer Center   (United States)

^j EORTC DATA CENTER   (Belgium)

^k Ospedale S Giovanni Vecchio   (Italy)

^l ST VINCENT S HOSPITAL   (Australia)

^m BICHAT HOSPITAL   (France)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o Azienda Ospedaliera   (Italy)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

^q YALE UNIVERSITY   (United States)

^r CENTRE EUGÈNE MARQUIS   (France)

^s UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^t CHRISTIE HOSPITAL   (United Kingdom)

^u HENRI MONDOR HOSPITAL   (France)

^v AICHI CANCER CENTER HOSPITAL   (Japan)

^w TOKAI UNIVERSITY   (Japan)

^x IBIS Trials Centre   (United Kingdom)

^y Faculty of Medicine Kragujevac   (Serbia)

^z INSTITUT CURIE   (France)

^aa BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^ab UNIVERSITY OF BERGEN   (Norway)

^ac A C CAMARGO CANCER CENTER   (Brazil)

^ad THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^ae CANCER INSTITUTE WIA   (India)

^af UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^ag CENTRE OSCAR LAMBRET   (France)

^ah Eastern Cooperative Oncology Group   (United States)

^ai KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^aj PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^ak CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^al UNIVERSITY OF GENOA   (Italy)

^am 9 Ashok Nagar Society   (India)

^an HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^ao UNIVERSITY OF TORONTO   (Canada)

^ap General Hospital   (Italy)

^aq Department of Statistics   (United States)

^ar TURKU UNIVERSITY HOSPITAL   (Finland)

^as UNIVERSITY OF COLORADO   (United States)

^at TATA MEMORIAL HOSPITAL   (India)

^au Centre de Radioterapia i Oncologica   (Spain)

^av CENTRE VAL D AURELLE   (France)

^aw OHIO STATE UNIVERSITY   (United States)

^ax UNIVERSITY OF LJUBLJANA   (Slovenia)

^ay Hôpital de la Pité Salpêtière   (France)

^az RUSH UNIVERSITY MEDICAL CENTER   (United States)

^ba SAITAMA MEDICAL UNIVERSITY   (Japan)

^bb MIDDLESEX HOSPITAL   (United Kingdom)

^bc UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^bd UNIVERSITY OF NORTH CAROLINA   (United States)

^be FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^bf UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^bg OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^bh JOHNS HOPKINS UNIVERSITY   (United States)

^bi NETHERLANDS CANCER INSTITUTE   (Netherlands)

^bj UNIVERSITY OF CALIFORNIA   (United States)

^bk NATIONAL CANCER INSTITUTE   (Italy)

^bl NHMRC Clinical Trials Centre   (Australia)

^bm MEDICAL RESEARCH COUNCIL   (United Kingdom)

^bn UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^bo Nhmrc Clinical Trials Center ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; META ANALYSIS; MOUTH CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

EID: 0034681783     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)90011-4     Document Type: Article

References (13)

1. Parkin, D.M., Muir, C.S., Whelan, S.L., Gao, Y.T., Ferlay, J., Powell, J. Cancer incidence in five continents. Vol 6. Lyon: IARC, 1992.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin 1996. 65:1996;5-27.
3. Vokes E.E., Weichselbaum R.R., Lippman S.M., Hong W.K. Head and neck cancer. N Engl J Med. 328:1993;184-194.
4. Hahari P. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol. 15:1997;2050-2055.
5. Schemper M., Smith T.L. A note on quantifying follow-up in studies of failure time. Controlled Clin Trials. 17:1996;343-346.
6. Yusuf S., Peto R., Lewis J., Collins R., Sleight T. Beta blockade during and after myocardial infarction: an overview of randomised clinical trials. Prog Cardiovasc Dis. 27:1985;335-371.
7. Stewart L.A., Parmar M.K.B. Meta-analysis of the literature or individual patient data: is there a difference? Lancet. 341:1993;418-422.
8. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 324:1991;1685-1690.
9. Richard J.M., Sancho-Garnier H., Pessey J.J.et al. Randomized trial of induction chemotherapy in larynx carcinoma. Eur J Cancer. 34:1998;224-228.
10. Lefebvre J.L., Chevalier D., Luboinski B.et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 88:1996;890-899.
11. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ. 311:1995;899-909.
12. Bourhis J., Pignon J.P. Meta-analyses in head and neck squamous cell carcinoma: what is the role of chemotherapy? Hematol Oncol Clin North Am. 13:1999;769-775.
13. Oxman A.D., Clarke M.J., Stewart L.A. From science to practice: meta-analyses using individual patient data are needed. JAMA. 274:1995;845-846.